Aclarion Expands CLUE Trial to New Jersey for Chronic Low Back Pain Diagnosis
Aclarion's CLUE trial, aimed at evaluating the impact of Nociscan's AI-generated data on chronic low back pain treatment plans, expands to New Jersey with Dr. Justin Kubeck joining the study. This expansion marks a significant step in gathering real-world evidence for the utility of Nociscan in spine care.
Read the full story




























